Abstract:Background Multiple myeloma (MM) is a terminally differentiated plasma cell hematological malignancy. MM remained an incurable disease, accounting for 20% of deaths of hematological malignancies, despite continuous improvements in its treatment. The revised international staging system (RISS) is commonly used in patients with de novo MM, but it has limitations in predicting prognosis. Hence, better prognostic biomarkers and more optimized staging are yet to be explored. Methods This retrospective study reviewed 357 patients with MM at our institution from May 2013 to May 2018 and included a total of 302 patients. Differences in serum ferritin levels between patients with relapse/non-relapse and survival/death were assessed. Multivariate-adjusted Cox regression and K-M curve were conducted to analyze the effect of different serum ferritin levels on progression-free survival (PFS) and overall survival (OS) in 7 years. Further, the receiver operating characteristic (ROC) curve analysis was used to evaluate the role of serum ferritin level in increasing the international staging system (ISS) and RISS in prognosis prediction. Multivariate linear regression and binomial logistic regression assessed the association of serum ferritin level with optimal induction therapy response. Results The serum ferritin level of patients with MM with recurrence was significantly higher than that of patients without recurrence (P < 0.0001), and the serum ferritin level of patients with all-cause death was significantly higher than that of patients who were still alive during the 7-year follow-up period (P < 0.0001). Smooth curve fitting analysis showed that serum ferritin levels were associated with relapse and death occurrences. The K-M curve analysis indicated that MM patients with high ferritin levels (≥577.47 ng/ml) had shorter PFS (P < 0.0056) and OS (P = 0.0014) than those with ferritin levels of <577.47 ng/ml. Multivariate Cox regression analysis adjusted for potential variables showed that MM patients with high serum ferritin had poor PFS (hazard ratio [HR] = 2.07, 95% confidence interval [CI]: 1.33-3.23, P = 0.0012) and OS (HR = 1.84, 95%CI: 1.08-3.16, P = 0.0258), with independent correlation. The prediction model of ROC analysis based on Cox regression showed that ferritin had a predictive value for PFS (ORferritin = 2.158, Pferritin = 0.0219) and OS (ORferritin = 2.2480, Pferritin = 0.0196). Additionally, the ROC curve showed that serum ferritin could increase the predictive value of ISS and RISS for OS. Multivariate regression analysis showed that serum ferritin levels had no significant independently effect on the optimal response within induction therapy. Conclusion This retrospective study showed that baseline serum ferritin levels were associated with prognosis in patients with MM, and patients with higher serum ferritin have poorer PFS and OS. Serum ferritin could increase the prediction value of ISS and RISS for OS.

Impact of Serum Ferritin and Iron Overload on Acute Myeloid Leukemia Outcomes: A Systematic Review and Meta-Analysis

Iron Metabolism Before Allo-Hsct in Patients with Acute Leukemia and Impact of Iron Overload on Transplantation

The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia

A Meta-Analysis for Effects of Elevated Pre-Transplantation Serum Ferritin on the Outcomes in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Elevated Serum Ferritin Levels Are Associated with Severity and Prognosis of Severe Acute Pancreatitis: a Preliminary Cohort Study

Iron overload promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of FOS

Association of iron overload with infectious complications in liver transplant recipients: a systematic review and meta-analysis

Iron Overload in Children with Acute Lymphoblastic and Acute Myeloblastic Leukemia—Experience of One Center

The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis.

Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study

Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome

Iron and ferritin effects on intensive care unit mortality: A meta-analysis

Significance of the Research on the Relevance of Bone Marrowiron Stain and Serum Ferritin in the Diagnosis of Anemic Disease

Clinical outcomes of transfusion-associated iron overload in patients with refractory chronic anemia.

Serum Ferritin and the Risk of Short-Term Mortality in Critically Ill Patients with Chronic Heart Failure: a Retrospective Cohort Study

Effect of Elevated Serum Ferritin on the Risk of Death in Patients with Decompensated Cirrhosis: a Meta-Analysis

Impact of Iron Overload and Iron Chelation with Deferasirox on Outcomes of Patients with Severe Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.

Dose-response relationship of serum ferritin and dietary iron intake with metabolic syndrome and non-alcoholic fatty liver disease incidence: a systematic review and meta-analysis

Study of Abnormal Iron Metabolism Parameters and Iron Overload in Patients with Myelodysplastic Syndromes

Serum Ferritin Increased the Predictive Value of the International Staging System/Revised International Staging System for Overall Survival

The Impact of Iron on Cancer-Related Immune Functions in Oncology: Molecular Mechanisms and Clinical Evidence